Acute myeloid leukemia in the elderly: do we know who should be treated and how?


Abstract Acute myeloid leukemia (AML) in the elderly is associated with several distinctive biological and clinical features compared to younger patients. Despite the advances in supportive care and the introduction of less intensive chemotherapy regimens, the overall outcome for this population remains poor. More importantly, the decision making process… (More)
DOI: 10.3109/10428194.2013.828348


  • Presentations referencing similar topics